200 related articles for article (PubMed ID: 2162506)
1. A low-molecular-weight heparin (Kabi 2165, 'Fragmin') in repeated use for haemodialysis: prevention of clotting and prolongation of the venous compression time in comparison with commercial unfractionated heparin.
Anastassiades E; Ireland H; Flynn A; Lane DA; Curtis JR
Nephrol Dial Transplant; 1990; 5(2):135-40. PubMed ID: 2162506
[TBL] [Abstract][Full Text] [Related]
2. A low molecular weight heparin ("fragmin") for routine hemodialysis: a crossover trial comparing three dose regimens with a standard regimen of commercial unfractionated heparin.
Anastassiades E; Lane DA; Ireland H; Flynn A; Curtis JR
Clin Nephrol; 1989 Dec; 32(6):290-6. PubMed ID: 2558829
[TBL] [Abstract][Full Text] [Related]
3. Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo.
Eichinger S; Wolz M; Nieszpaur-Los M; Schneider B; Lechner K; Eichler HG; Kyrle PA
Thromb Haemost; 1994 Dec; 72(6):831-5. PubMed ID: 7740450
[TBL] [Abstract][Full Text] [Related]
4. Heparins and blood polymorphonuclear stimulation in haemodialysis: an expansion of the biocompatibility concept.
Leitienne P; Fouque D; Rigal D; Adeleine P; Trzeciak MC; Laville M
Nephrol Dial Transplant; 2000 Oct; 15(10):1631-7. PubMed ID: 11007833
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the anticoagulant effect of low-molecular-weight heparins based on the anti-Xa level during haemodialysis.
Tao M; Zheng D; Liang X; Ye M; Liu Y; Li Y; Shen H; He Q
Nephrology (Carlton); 2020 Sep; 25(9):723-729. PubMed ID: 31999031
[TBL] [Abstract][Full Text] [Related]
6. On the evaluation of heparin and low molecular weight heparin in haemodialysis for chronic renal failure.
Lane DA; Flynn A; Ireland H; Anastassiades E; Curtis JR
Haemostasis; 1986; 16 Suppl 2():38-47. PubMed ID: 3744134
[TBL] [Abstract][Full Text] [Related]
7. Haemodialysis with low MW heparin: dosage requirements for the elimination of extracorporeal fibrin formation.
Lane DA; Ireland H; Flynn A; Anastassiades E; Curtis JR
Nephrol Dial Transplant; 1986; 1(3):179-87. PubMed ID: 2955253
[TBL] [Abstract][Full Text] [Related]
8. Effects of recombinant hirudin (r-hirudin, HBW 023) on coagulation and platelet activation in vivo. Comparison with unfractionated heparin and a low-molecular-weight heparin preparation (fragmin).
Eichinger S; Wolzt M; Schneider B; Nieszpaur-Los M; Heinrichs H; Lechner K; Eichler HG; Kyrle PA
Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):886-92. PubMed ID: 7600120
[TBL] [Abstract][Full Text] [Related]
9. Low molecular weight heparin and haemodialysis: neutralization by protaminchloride.
Andrassy K
Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S39-43. PubMed ID: 8180328
[TBL] [Abstract][Full Text] [Related]
10. Dose finding study of a low molecular weight heparin, Innohep, in haemodialysis.
Ryan KE; Lane DA; Flynn A; Shepperd J; Ireland HA; Curtis JR
Thromb Haemost; 1991 Sep; 66(3):277-82. PubMed ID: 1745997
[TBL] [Abstract][Full Text] [Related]
11. Fibrinolytic and anticoagulant activity after a single subcutaneous administration of a low dose of heparin or a low molecular weight heparin-dihydroergotamine combination.
Grimaudo V; Omri A; Kruithof EK; Hauert J; Bachmann F
Thromb Haemost; 1988 Jun; 59(3):388-91. PubMed ID: 2847348
[TBL] [Abstract][Full Text] [Related]
12. Clinical study on low-molecular weight heparin infusion as anticoagulation for nocturnal home haemodialysis.
Wong SS; Lau WY; Ng ML; Chan SY; Chan SF; Chan PK; Wan CK; Cheng YL
Nephrology (Carlton); 2018 Apr; 23(4):317-322. PubMed ID: 28052451
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio].
Barata JD; Oliveira C; Bruges M; Gusmão L; Santana A; Ponce P; Simões J; Freire I; Crespo F; da Silva AN
Acta Med Port; 1992 Feb; 5(2):65-70. PubMed ID: 1317657
[TBL] [Abstract][Full Text] [Related]
14. A cross-over study of a new low molecular weight heparin (Logiparin) in hemodialysis.
Koutsikos D; Fourtounas C; Kapetanaki A; Dalamanga A; Tzanatos H; Agroyannis B; Kopelias I; Bosiolis B; Rammos G; Bovoleti O; Sallum G; Darema M
Int J Artif Organs; 1996 Aug; 19(8):467-71. PubMed ID: 8841845
[TBL] [Abstract][Full Text] [Related]
15. Low molecular weight heparin (CY-216) versus unfractionated heparin in chronic hemodialysis.
Grau E; Sigüenza F; Maduell F; Linares M; Olaso MA; Martinez R; Caridad A
Nephron; 1992; 62(1):13-7. PubMed ID: 1331831
[TBL] [Abstract][Full Text] [Related]
16. Different effects of enoxaparin and unfractionated heparin on extrinsic blood coagulation during haemodialysis: a prospective study.
Naumnik B; Borawski J; Myśliwiec M
Nephrol Dial Transplant; 2003 Jul; 18(7):1376-82. PubMed ID: 12808176
[TBL] [Abstract][Full Text] [Related]
17. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
[TBL] [Abstract][Full Text] [Related]
18. [Effect of unfractionated and low-molecular-weight heparin on platelet aggregation and in vitro bleeding time in dogs].
Nimmerfall K; Mischke R
Dtsch Tierarztl Wochenschr; 1999 Oct; 106(10):439-44. PubMed ID: 10589154
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulant-free Genius haemodialysis using low molecular weight heparin-coated circuits.
Frank RD; Müller U; Lanzmich R; Groeger C; Floege J
Nephrol Dial Transplant; 2006 Apr; 21(4):1013-8. PubMed ID: 16326745
[TBL] [Abstract][Full Text] [Related]
20. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
